Site Navigation
Clinical Studies for Children and Adolescents with Autism Spectrum Disorder,
Pervasive Developmental Disorder (PDD), and Other Disorders
Our list of studies provides contact information and links to basic participation requirements.
Please check this page frequently. New studies will be posted prior to subject recruitment.
Current Autism and PDD Studies
Treatment of Irritability and Aggression Associated with Autistic Disorder
Memantine in Pediatric Patients with Autism
Preschool Parent Management Training Study
Cholesterol in ASD: Characterization and Treatment
Study of Investigational Medication and Parent Training Sessions for Treatment of Overactivity, Inattention, and Impulsivity in Children Diagnosed with Autistic Disorder
Completed Autism and PDD Studies
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotics
CM-AT Enzyme vs. Placebo in the Treatment of Autism
Study of an Investigational Medication for Repetitive Behaviors in Children with Autistic Disorder
Research in Serious Behavioral Problems Associated With Autistic Disorder
Study of a Medication for Gastrointestinal Problems in Autistic Children
Study of the Pharmacokinetic Parameters of Risperidone in Patients with Autism Spectrum Disorders and Tourette Syndrome Ages 4 - 21
Risperidone on Cognitive Motor Performance and Motor Movements in Children with Disruptive Behavior Disorders
Pharmacogenetics of Risperidone in Children with PDD, Ages 4 -21 (Adults eligible)
A Study of Atomoxetine (Strattera™) for Children and Adolescents with Autism, Asperger's Syndrome, or other Pervasive Developmental Disorder (PDD) and Signs of Attention-Deficit/Hyperactivity Disorder (ADHD)
Ritalin® Treatment or Guanfacine for Hyperactivity/Impulsiveness in Children with Pervasive Developmental Disorders
Measurement of Risperidone and 9-hydroxyrisperidone in Saliva and Plasma